speb/financial-data huggingface dataset:
ABBV.TO balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 14304000000.00
ABBV.TO balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 14304000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 14304000000.00
ABBV.TO balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 14304000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 38749000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Deferred Income Tax: -1449000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Deferred Tax: -1449000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Depreciation: 764000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 8386000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 8386000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 16752921060.00
ABBV.TO income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 16715125412.00
ABBV.TO income_statement (annual, 2024-12-31) — Diluted EPS: 0.25
ABBV.TO income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.00
ABBV.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 4238000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Dividends Payable: 2936000000.00
ABBV.TO balance_sheet (quarterly, 2024-12-31) — Dividends Payable: 2936000000.00
ABBV.TO income_statement (annual, 2024-12-31) — EBIT: 6524000000.00
ABBV.TO income_statement (annual, 2024-12-31) — EBITDA: 14910000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -65000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Employee Benefits: 1234000000.00
ABBV.TO balance_sheet (quarterly, 2024-12-31) — Employee Benefits: 1234000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — End Cash Position: 5524000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -5211000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Finished Goods: 1173000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: 17832000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
ABBV.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -21000000.00
ABBV.TO income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: -19000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -1925000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Goodwill: 34956000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 95024000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 12267000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Gross Profit: 39430000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 4064000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Interest Expense: 2808000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 2808000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Interest Income: 648000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 648000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 2811000000.00
ABBV.TO cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 705000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Inventory: 4181000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 70469000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -20820000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Investments And Advances: 279000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 21971000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Land And Improvements: 284000000.00
ABBV.TO balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 284000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Long Term Debt: 60340000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 60340000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 16963000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -9613000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 7995000000.00
ABBV.TO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 7995000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Minority Interest: 39000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Minority Interests: -8000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -20517000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -1708000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Net Debt: 61620000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Net Income: 4278000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 4238000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 4286000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 4278000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 4278000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 4286000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 4286000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Net Interest Income: -2160000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 482000000.00
ABBV.TO cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 12000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 7350000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 7350000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -2160000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -42000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 189000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Net PPE: 5134000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -974000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -91699000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 2579000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 2579000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1234000000.00
ABBV.TO balance_sheet (quarterly, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1234000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: 17688000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Normalized Income: 6472620000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 18806000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Operating Income: 11894000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Operating Revenue: 56334000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 1765256986.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Other Current Assets: 4927000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -1925000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Other Income Expense: -6018000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 60068000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 4470000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 9142000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 27634000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -3240000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: -7000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Other Properties: 7995000000.00
ABBV.TO balance_sheet (quarterly, 2024-12-31) — Other Properties: 7995000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 31000000.00
ABBV.TO balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 31000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Other Special Charges: 2757000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 40000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Payables: 5881000000.00
ABBV.TO balance_sheet (quarterly, 2024-12-31) — Payables: 5881000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 31945000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Pretax Income: 3716000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 214000000.00
ABBV.TO cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 10000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Properties: 0.00
ABBV.TO balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
ABBV.TO cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 508000000.00
ABBV.TO cash_flow (quarterly, 2024-12-31) — Provisionand Write Offof Assets: 167000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Purchase Of Business: -20517000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -73000000.00
ABBV.TO cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: -27000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -974000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Raw Materials: 1057000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Receivables: 10919000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 16904000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 8386000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -14621000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -1708000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Research And Development: 12791000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: -7900000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Sale Of Investment: 555000000.00
ABBV.TO cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 39000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 14752000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Share Issued: 1831594494.00
ABBV.TO cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 5008000000.00
ABBV.TO cash_flow (quarterly, 2024-12-31) — Short Term Debt Issuance: 0.00
ABBV.TO cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -5008000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Special Income Charges: -2757000000.00
ABBV.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 911000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 3325000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: -91699000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -583380000.00
ABBV.TO income_statement (annual, 2024-12-31) — Tax Provision: -570000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
ABBV.TO balance_sheet (annual, 2024-12-31) — Total Assets: 135161000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 63665000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Total Debt: 67144000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 3364000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Total Expenses: 44440000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 131797000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 109579000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 93048000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 9137000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Total Unusual Items: -2778000000.00
ABBV.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -2778000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 1261000000.00
ABBV.TO balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 1261000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 66337508.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Treasury Stock: 8201000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Work In Process: 1951000000.00
ABBV.TO balance_sheet (annual, 2024-12-31) — Working Capital: -13167000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 5360000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 13343000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 12477000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -7334000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 21808000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 1858000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 1858000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 16689503544.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.08
ABBV.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 5524000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -235000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 18000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 5175000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 5176000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -2925000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -1258000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -735000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 1635000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -696000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Change In Inventory: -155000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 378000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Change In Payable: -696000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -696000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -628000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -1479000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -2580000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -1479000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -358000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 18000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -2925000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1420000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -961000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 4002000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 27675000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Current Debt: 5362000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 5362000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 36403000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -28000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: -28000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 181000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2039000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 2039000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 16743472148.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.08
ABBV.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1276000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — EBIT: 2361000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — EBITDA: 4400000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 9000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 5175000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -1258000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Finished Goods: 1441000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 1400000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -4000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -1742000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Goodwill: 35285000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 93774000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 12571000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 9341000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 700000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 700000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Interest Income: 73000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 73000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 4526000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 71309000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -735000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 287000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 5587000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 64527000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 64527000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 3994000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -3026000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Minority Interest: 42000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Minority Interests: -3000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -538000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -961000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Net Debt: 64714000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Net Income: 1286000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1276000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1289000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1286000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1286000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 1289000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1289000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -627000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 22000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 2561000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 968000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -627000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 67000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 38000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 5237000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -235000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 1593000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -92354000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 2582000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2582000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 4648000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 1478457555.69
ABBV.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 1635000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Operating Income: 3981000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 13343000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 1766288379.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 5496000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -1742000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: -1693000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 58489000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 505000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 9192000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 31191000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -1445000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Other Special Charges: 248000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 10000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 31041000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 1661000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 56000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -538000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -10000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -235000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Raw Materials: 1111000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 12477000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 4002000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2039000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -3026000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -961000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Research And Development: 2067000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -9527000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 32000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 3293000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 1837071074.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 1593000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: 0.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Special Income Charges: -248000000.00
ABBV.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 410000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1420000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -92354000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -55542444.31
ABBV.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 372000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.22
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 136165000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 65947000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 69889000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1462000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 9362000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 134703000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 108490000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 98300000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 3733000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: -248000000.00
ABBV.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -248000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 70782695.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 9137000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Work In Process: 1974000000.00
ABBV.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: -8728000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 5360000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 15423000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 12637000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -7651000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 21987000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 1864000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 1864000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 16691135702.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.06
ABBV.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 5175000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -269000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 18000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 6467000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 6467000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -2910000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -2710000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1181000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 5153000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 515000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: -56000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -1375000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: 515000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 515000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 371000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -17000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -562000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -17000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1262000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 18000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -2910000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -183000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -12000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 4346000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 29261000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Current Debt: 7522000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 7522000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 39767000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -272000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: -272000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Depreciation: 186000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2050000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2050000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 16734023236.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.06
ABBV.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 928000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — EBIT: 2294000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — EBITDA: 4344000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 30000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 6467000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -2710000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Finished Goods: 1681000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 4884000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -23000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -1538000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Goodwill: 35638000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 92669000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 12934000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 11077000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 740000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 740000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Interest Income: 62000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 62000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 4960000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 70298000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1181000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 310000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 3963000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 62959000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 62959000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -3754000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Minority Interest: 45000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Minority Interests: -3000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -940000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -12000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 64014000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Net Income: 938000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 928000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 941000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 938000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 938000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 941000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 941000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -678000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -5000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 209000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -3754000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -678000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -58000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 11000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 5283000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -269000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 3963000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -92852000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 2554000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 2554000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 5190000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 1450281853.28
ABBV.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 5153000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Operating Income: 5717000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 15423000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1766461114.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 5197000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -1538000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: -3485000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 57031000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 3567000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 9659000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 32040000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -2639000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -24000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 0.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Other Special Charges: 823000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 10000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 32245000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 1554000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 5000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -940000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -12000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -269000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Raw Materials: 1166000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 12637000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 4346000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2050000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -3754000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -12000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Research And Development: 2131000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -11503000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 7000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 3253000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 1837290114.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 3963000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: 0.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: -823000000.00
ABBV.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 179000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -183000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -92852000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -333718146.72
ABBV.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 613000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.39
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 137182000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 62776000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 70481000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -138000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 9706000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 137320000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 107921000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 97553000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 4894000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -846000000.00
ABBV.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -846000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 70829000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 9147000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Work In Process: 2113000000.00
ABBV.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: -10506000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 5888000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 15776000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 12769000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -7746000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 22291000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 1871000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 1871000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 16699533554.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Basic EPS: 0.01
ABBV.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 6467000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -381000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 18000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 5629000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 5671000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -2911000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -4590000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -3264000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 7024000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 1730000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Change In Inventory: 2000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -411000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: 1730000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1730000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 88000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -156000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1253000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -156000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -830000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 18000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -2911000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -2642000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -4000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 5304000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 28539000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Current Debt: 5772000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 5772000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 39391000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 193000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: 193000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Depreciation: 192000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2063000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 2063000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 176000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — EBIT: 1453000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — EBITDA: 3516000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -8000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 5629000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -4590000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Finished Goods: 1579000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 6643000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -20000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -1574000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Goodwill: 35626000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 89941000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 13229000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 10472000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Interest Expense: 739000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 739000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Interest Income: 72000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 72000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 739000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 4938000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 66101000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -3264000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 291000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 241000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 62971000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 62971000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -9000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Minority Interest: 43000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Minority Interests: -2000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -2802000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -4000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Net Debt: 63114000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Net Income: 186000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 176000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 188000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 186000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 186000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 188000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 188000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: -667000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -4000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -1775000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -9000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -667000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 37000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -77000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 5483000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -381000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -1766000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -92583000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 2480000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 2480000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 6216000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 2319000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 7024000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Operating Income: 4584000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 15776000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1767349878.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 5161000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -1574000000.00
ABBV.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: -3203000000.00
ABBV.TO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 54315000000.00
ABBV.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 2590000000.00